Randomized Study of Orphenadrine' in the Treatment of Muscle Cramps in Patients With Cirrhosis

Who is this study for? Patients with Liver Cirrhosis, Muscle Cramps
What treatments are being studied? Orphenadrine
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 3
SUMMARY

Muscle cramps are common in patients with liver disease and associated with significantly diminished quality of life. Patients with cirrhosis often experience muscle cramps with varied frequency and severity. The exact mechanisms by which they occur remain unclear, although a number of pathophysiological events unique to liver disease may contribute. Clinical studies have identified alterations in 3 areas: nerve function, energy metabolism, and plasma volume/electrolytes (1) Orphenadrine is an anticholinergic drug with prominent central nervous system (CNS) and peripheral actions used to treat painful muscle spasms and other similar conditions. The combination of anticholinergic effects and CNS penetration make orphenadrine useful for pain of all etiologies, including from: radiculopathy, muscles, and headaches. \[3,4\]

Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:

• Cirrhosis

• Muscle cramps( ≥3 cramps per week )

Locations
Other Locations
Egypt
Tanta university hospital
RECRUITING
Tanta
Contact Information
Primary
Sherief M Abd-Elsalam, lecturer
Sherif_tropical@yahoo.com
01000058842
Time Frame
Start Date: 2015-01
Estimated Completion Date: 2028-12
Participants
Target number of participants: 100
Treatments
Experimental: Orphenadrine(Norflex)
50 patients will be treated with orphenadrine 100 mg twice daily for 1 month
Placebo_comparator: Placebo
50 patients will be given placebo
Related Therapeutic Areas
Sponsors
Collaborators: Tanta University
Leads: Sherief Abd-Elsalam

This content was sourced from clinicaltrials.gov